BLUE : Insider Transactions for Bluebird Bio, Inc. | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Bluebird Bio, Inc. (BLUE)

$1.02

0.04 (3.77%) as of 4:30 Mon 5/13

Download

Exchange:

N/A

Security Type:

Common

Shares Out:

139,126,000

Market Cap:

141.91(M)

Last Volume:

0

Avg Vol:

0

52 Week Range:

$0.8871 - $4.83

Level I Sector:

Health Care

Level II Sector:

Drugs

Level III Sector:

Biotechnology

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year

Company Profile bluebird bio is a company focused on the pursuit of curative gene therapies for severe genetic diseases. Co. has late-stage clinical and research programs for the treatment of sickle cell disease (SCD), ss-thalassemia and cerebral adrenoleukodystrophy and is developing research to apply new technologies to these and other diseases. Using a proprietary lentiviral vector platform, Co. custom designs each of its therapies to address the underlying cause of disease by introducing a functional copy of a gene to patients' own isolated hematopoietic stem cells. Co. is developing lovotibeglogene autotemcel as a one-time treatment for patients with SCD.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	0	0
Total Buy Value	$0	$0	$0	$0
Total People Bought	0	0	0	0
Total Buy Transactions	0	0	0	0
Total Shares Sold	17,438	35,533	57,514	116,582
Total Sell Value	$26,639	$61,294	$139,194	$443,003
Total People Sold	3	5	5	9
Total Sell Transactions	3	9	12	23
End Date	2024-02-11	2023-11-10	2023-05-12	2022-05-12

Adjust Filter Settings

Records found: 939

Page 15 of 38

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Walsh Jeffrey T.

Chief Financialand Strategy Of

• – –

2018-09-10

4

OE

$24.47

$36,705

D/D

1,500

36,995

-

Director

– • –

2018-09-10

4

AS

$150.06

$150,771

D/D

(1,000)

1,000

-

Gregory Philip D

Chief Scientific Officer

• – –

2018-09-05

4

AS

$161.83

$293,441

D/D

(1,800)

31,871

-

Gregory Philip D

Chief Scientific Officer

• – –

2018-09-05

4

OE

$50.51

$83,226

D/D

1,300

33,671

-

Chief Medical Officer

• – –

2018-09-04

4

AS

$165.53

$1,166,493

D/D

(7,000)

24,905

-

Chief Medical Officer

• – –

2018-09-04

4

OE

$5.50

$38,503

D/D

7,000

31,905

-

Walsh Jeffrey T.

Chief Financialand Strategy Of

• – –

2018-08-30

4

AS

$175.37

$3,507,948

D/D

(20,000)

35,495

-

Walsh Jeffrey T.

Chief Financialand Strategy Of

• – –

2018-08-30

4

OE

$2.09

$217,689

D/D

20,000

55,495

-

Finger Alison Cecily

Chief Commercial Officer

• – –

2018-08-20

4

S

$158.05

$40,940

D/D

(259)

15,667

-

Walsh Jeffrey T.

Chief Financialand Strategy Of

• – –

2018-08-10

4

AS

$155.41

$235,389

D/D

(1,500)

35,495

-

Walsh Jeffrey T.

Chief Financialand Strategy Of

• – –

2018-08-10

4

OE

$5.50

$8,251

D/D

1,500

36,995

-

Chief Legal Officer

• – –

2018-08-08

4

OE

$22.53

$99,988

D/D

4,438

21,610

-

Gregory Philip D

Chief Scientific Officer

• – –

2018-08-06

4

AS

$156.51

$281,889

D/D

(1,800)

32,371

-

Gregory Philip D

Chief Scientific Officer

• – –

2018-08-06

4

OE

$50.51

$83,226

D/D

1,300

34,171

-

Walsh Jeffrey T.

Chief Financialand Strategy Of

• – –

2018-08-02

4

AS

$150.31

$3,268,493

D/D

(21,500)

35,495

-

Walsh Jeffrey T.

Chief Financialand Strategy Of

• – –

2018-08-02

4

OE

$5.50

$118,259

D/D

21,500

56,995

-

Chief Medical Officer

• – –

2018-08-02

4

AS

$150.18

$1,052,585

D/D

(7,000)

24,905

-

Chief Medical Officer

• – –

2018-08-02

4

OE

$5.50

$38,503

D/D

7,000

31,905

-

Chief Medical Officer

• – –

2018-07-11

4

AS

$180.15

$540,443

D/D

(3,000)

24,905

-

Chief Medical Officer

• – –

2018-07-11

4

OE

$5.50

$16,501

D/D

3,000

27,905

-

Chief Legal Officer

• – –

2018-07-09

4

AS

$168.47

$872,715

D/D

(5,126)

17,172

-

Chief Medical Officer

• – –

2018-07-02

4

AS

$153.36

$1,539,604

D/D

(10,000)

24,905

-

Chief Medical Officer

• – –

2018-07-02

4

OE

$5.50

$55,004

D/D

10,000

34,905

-

Director

– • –

2018-06-20

4

A

$0.00

$0

D/D

1,000

3,000

-

Schenkein David P

Director

– • –

2018-06-20

4

A

$0.00

$0

D/D

1,000

4,176

-

939 Records found	Previous 10 11 12 13 14 15 16 17 18 19 Next	Page 15 of 38

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.